Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 12, 1997

View Archived Issues

Proteome project collaboration announced

Bigmar to enter potential collaboration; Regains rights to oncology products

Xytronyx changes name to Pacific Pharmaceuticals

Organogenesis receives FDA clearance for Graftpatch

Studies imply role of relaxin in infertility treatments

Bristol-Myers Squibb: Q2 1997 highlights

Imminent launch of Novartis' Alzheimer's disease therapy

Normiflo launched in U.S.

Living wound care product launched in Canada

Amarillo Biosciences completes enrollment for phase II study on Sjogren's syndrome

Federal district court favors Geneva in ranitidine patent litigation

EntreMed and the National Cancer Institute sign letters of intent

Shaman: Q2 1997 highlights

New angiotensin II blocker from Merck KGaA

Bayer reports LTB4 synthesis inhibitors for asthma

MMP/TNF-alpha inhibitors from Novartis

RPR seeks U.S. and European approval for estrogen/progestogen transdermal patch

Settlement reached in NeXstar and The Liposome Company patent litigation

Lidak licenses ADIFAB technology to Aurora Biosciences

Lilly and Acacia Biosciences sign research collaboration

Briana Bio-Tech acquires breast cancer detection system

Cangene signs licensing and distribution agreement for Leucotropin

Diversa reaches milestone in Finnfeeds agreement

Andaris files IND application for Quantison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...